ClinicalTrials.Veeva

Menu
R

Retina Consultants of Charleston | Retina Research of Beaufort

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

KSI-301
Aflibercept
Zimura
OCS-01
Avacincaptad pegol
dexamethasone

Parent organization

This site is a part of Retina Consultants of Charleston

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)

The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of OCS- 01 as compared to Vehicle...

Active, not recruiting
Diabetic Macular Edema
Drug: Dexamethasone ophthalmic suspension (OCS-01)
Drug: Vehicle

ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular d...

Enrolling
Wet Age-related Macular Degeneration
WetAMD
Biological: Aflibercept (EYLEA®)
Genetic: ABBV-RGX-314 Dose 2

Trial sponsors

Kodiak Sciences logo
AbbVie logo
Astellas logo
I
O

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems